Skip to content

CPAICounterpoint Quantitative Equity ETF

Grow my money2y track recordRanked #1,482 of 2,999 in this goal

Seeks long-term capital appreciation.

By Counterpoint Funds · Launched 2023

Annual Cost

0.75%

#3,925 of 5,861 · average

Fund Size

$369M

#1,832 of 5,861 · large

Return (1Y)Goal

+42.4%

Track Record

2 years

#3,223 of 5,861 · seasoned

Performance

Total-return NAV · USD
Growth of $10,000
$14,272+42.7%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Systematic alpha

Focus

Artificial Intelligence

What it actually holds

By weight

Concentration

Top 10 holdings = 20.2% of fundwell diversified

Adaptive Biotechnologies Corp
2.0%
Vertex Inc
2.0%
Lightpath Technologies Inc.
2.0%
Viavi Solutions Inc
2.0%
EZCORP Inc.
2.0%
The Realreal Inc
2.0%
Marqeta Inc
2.0%
United Natural Foods, Inc.
2.0%
International Business Machines Corp.
2.0%
Star Bulk Carriers Corp.
2.0%

Asset allocation

Stocks
100.2%

By sector

Technology
34.1%
Healthcare
28.0%
Energy
12.0%
Industrials
8.1%
Consumer Defensive
4.1%
Communication
4.0%
Basic Materials
3.9%
Consumer Cyclical
3.9%
Other
1.9%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
19.6%Moderate

Year-on-year price swings

Max drawdown
-21.5%Moderate

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
New York Stock Exchange

Full fund details

Objective
Seeks long-term capital appreciation.
Strategy
Actively manages a portfolio using a quantitative, model-based approach to select common stocks and ADRs of U.S. domiciled companies across any market capitalization. The strategy focuses on stocks ranked by the Counterpoint Machine Learning Model, which incorporates themes of value, momentum, and profitability, with sector exposure limited to 35% and industry exposure to 25%.
Inception date
November 28, 2023
Fund family
Counterpoint Funds

What's next?

You've looked at CPAI. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

Data updated on 2026-08-04